Sana Biotechnology Inc (SANA) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $4.27
• Market Cap: $1.11B
• EPS: $-0.96
• 52-Week High: $6.55
• 52-Week Low: $1.26

Market Sentiment

Sana Biotechnology Inc currently has a Neutral sentiment score of 0.10.

About Sana Biotechnology Inc

Sana Biotechnology, Inc. is a leading biotechnology company based in Seattle, Washington, dedicated to pioneering engineered cell therapies to address critical unmet medical needs across various disease areas. Utilizing its advanced cell-engineering platform, Sana focuses on innovative treatments in gene therapy and regenerative medicine, aiming to transform existing therapeutic approaches and improve patient outcomes. With a robust pipeline supported by strong research and development initia...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Sana Biotechnology Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does SANA pay dividends?

Sana Biotechnology Inc (SANA) does not currently pay a regular dividend.

What is SANA's market cap?

Sana Biotechnology Inc (SANA) has a market capitalization of $1.11B with a current stock price of $4.27.